Preclinical studies and drug combination of low-cost molecules for Chagas disease

Chagas disease is caused by the protozoan Trypanosoma cruzi (T. cruzi). It remains the major parasitic disease in Latin America and is spreading worldwide, affecting over 10 million people. Hundreds of new compounds with trypanosomicidal action have been identified from different sources such as syn...

Full description

Bibliographic Details

Main Author:	Aguilera, Elena (author)
Other Authors:	Sánchez, Carina (author), Cruces, María Eugenia (author), Dávila Saralegui, Belén (author), Minini Rivas, Lucía (author), Mosquillo, María Florencia (author), Pérez-Díaz, Leticia (author), Serna, Elva (author), Torres, Susana (author), Schini, Alicia (author), Sanabria, Luis (author), Vera de Bilbao, N.I. (author), Yaluff, Gloria (author), Zolessi, Flavio R. (author), Ceilas, Luis Fabian (author), Cerecetto, Hugo (author), Álvarez, Guzmán (author)
Format:	article
Language:	English
Published:	2023
Subjects:	Chagas disease Pre-clinically studied Drug combination RMN metabolomics
Online Access:	https://hdl.handle.net/20.500.12008/43097
Tags:	Add Tag No Tags, Be the first to tag this record!